Rapid generation of mouse models with defined point mutations by the CRISPR/Cas9 system

Masafumi Inui1, Mami Miyado2, Maki Igarashi2

  • 1Department of Systems BioMedicine, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan.

Scientific Reports
|June 24, 2014
PubMed
Summary

CRISPR/Cas9 enables rapid, cost-effective in vivo point mutations in mice, validating in vitro findings and patient mutations. This powerful genome editing technique allows single amino acid substitutions in proteins for in vivo studies.